Clinical trial
Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated…
NCT00331136 · Medicines for Malaria Venture, Other · Completed
Key facts
| NCT number | NCT00331136 |
|---|---|
| Title | Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria |
| Official title | An Open-label, Phase II, Dose-Escalation Clinical Study to Assess the Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of Fixed Dose Combination of Pyronaridine and Artesunate (3:1) in Children With Acute Falciparum Malaria |
| Lead sponsor | Medicines for Malaria Venture, Other |
| Collaborators | Shin Poong Pharmaceuticals Industry Institute of Tropical Medicine, University of Tuebingen |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Uncomplicated Plasmodium Falciparum Malaria |
| Intervention type | Drug |
| Interventions | Pyronaridine-Artesunate |
| Enrollment | 60 |
| Start date | Jun 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | May 29, 2006 |
| Last update posted | May 5, 2022 |
| Countries | Gabon |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: